Outbreaks of avian influenza virus (AIV) an infection included the unfold of extremely pathogenic AIV in business poultry and yard flocks within the spring of 2015. This resulted in estimated losses of greater than $8.5 million from federal authorities expenditures, $1.6 billion from direct losses to produces arising from destroyed turkey and hen egg manufacturing, and economy-wide oblique prices of $3.Three billion from impacts on retailers and the meals service industries.
Moreover, these outbreaks resulted within the loss of life or depopulation of almost 50 million home birds. Domesticated male ferrets (Mustela putorius furo) had been educated to show a selected conditioned habits (i.e. energetic scratch alert) in response to feces from AIV-infected mallards compared to feces from wholesome geese. So as to set up that ferrets had been figuring out samples based mostly on odors related to an infection, extra experiments managed for probably confounding results, comparable to: particular person duck id, housing and feed, inoculation focus, and day of pattern assortment (post-infection).
A last experiment revealed that educated ferrets might detect AIV an infection standing even within the presence of samples from mallards inoculated with Newcastle illness virus or infectious laryngotracheitis virus. These outcomes point out that mammalian biodetectors are able to discriminating the particular odors emitted from the feces of non-infected versus AIV contaminated mallards, suggesting that the well being standing of waterfowl might be evaluated non-invasively for AIV an infection through monitoring of unstable fecal metabolites. Moreover, in situ monitoring utilizing educated biodetectors could also be an efficient device for assessing inhabitants well being.
H7N9 influenza virus-like particle based mostly on BEVS protects chickens from deadly problem with extremely pathogenic H7N9 avian influenza virus
H7N9 avian influenza virus poses a twin menace to each poultry trade and public well being. Subsequently, it’s extremely pressing to develop an efficient vaccine to scale back its pandemic potential. Virus-like particles (VLP) symbolize an efficient method for pandemic vaccine improvement. On this research, a recombinant baculovirus co-expressing the HA, NA and M1 genes of the H7N9 virus was constructed for era of H7N9 VLP. Single immunization of chickens with 15 μg of the VLP or the business complete virus inactivated vaccine stimulates excessive hemagglutination inhibition, virus neutralizing and HA-specific IgY antibodies. Furthermore, the antiserum had a great cross-reactivity with H7N9 discipline strains remoted in several years.
Inside 14 days after a deadly problem with extremely pathogenic (HP) H7N9 virus, no scientific signs and loss of life had been noticed within the vaccinated chickens, and no virus was recovered from the organs. In comparison with the non-vaccinated chickens, H7N9 VLP considerably decreased the proportion of animals shedding virus. Solely 30 % of the VLP-vaccinated birds shed virus, whereas virus shedding was detected in 50 % of the chickens immunized with the business vaccine.
Furthermore, each vaccines dramatically alleviated pulmonary lesions attributable to HP H7N9 virus, with a better diploma noticed for the VLP. Altogether, our outcomes indicated that the H7N9 VLP vaccine candidate confers an entire scientific safety towards a deadly problem with HP H7N9 virus, considerably inhibits virus shedding and abolishes viral replication in chickens. The VLP generated on this research represents a promising various technique for the event of novel H7N9 avian influenza vaccines for chickens.
Towards Growing Therapies towards Corona Virus: Synthesis and Anti-Avian Influenza Virus Exercise of Novel Cytosine Thioglycoside Analogues
A sequence of pyrimidine and pyrimidine thioglycoside derivatives had been newly synthesized utilizing sodium 2-cyano-3-(arylamino)prop-1-ene-1,1-bis(thiolates) and urea to offer the corresponding sodium 6-amino-5-aryl-2-oxo-1,2-dihydropyrimidine-4-thiolates. Stirring of the latter with peracetylated α-d-gluco- and galacto-pyranosyl bromides in DMF afforded the corresponding pyrimidine thioglycosides.
Alternatively, therapy of 6-amino-5-aryl-2-oxo-1,2-dihydropyrimidine-4-thiolate salts with hydrochloric acid produced the corresponding pyrimidine-4-thioles, which on stirring with α-d-gluco- and galacto-pyranosyl bromides in sodium hydride and DMF gave the corresponding pyrimidine thioglycosides. Deacetylation of the protected pyrimidine thioglycosides gave the corresponding free pyrimidine thioglycosides. The synthesized compounds have been characterised by 13C NMR, 1H NMR, and IR spectroscopy.
The pyrimidine thioglycosides and free pyrimidine thioglycosides had been examined towards avian influenza H5N1 virus pressure and exhibited highest to reasonable exercise.

Inhabitants genomic transformations induced by isolation of untamed fowl avian influenza viruses (Orthomyxoviridae) in embryonated hen eggs
Isolation and cultivation of wild-type viruses in mannequin organism cells or tissues is normal apply in virology. Oftentimes, the virus host species is distantly associated to the species from which the tradition system was developed. Thus, virus tradition in these tissues and cells principally constitutes a bunch leap, which might result in genomic modifications by means of genetic drift and/or adaptation to the tradition system.
We immediately sequenced 70 avian influenza virus (Orthomyxoviridae) genomes from oropharyngeal/cloacal swabs collected from wild fowl species and paired virus isolates propagated from the identical samples following isolation in specific-pathogen-free embryonated hen eggs. The info had been analyzed utilizing inhabitants genetic approaches together with analysis of single nucleotide polymorphism (SNP) frequencies and divergence with pooled-sequencing analyses, consensus sequence placement in neighbor-joining bushes, and haplotype reconstruction and networks.
We discovered that propagation of virus in eggs results in skewed SNP mutation spectra with some SNPs going to fixation. Each synonymous and nonsynonmous SNP frequencies shifted. We discovered a number of consensus sequences that differed between the swabs and the isolates, with some sequences from the identical pattern falling into divergent genetic clusters.
Twenty of 23 coinfections detected had totally different dominant subtypes following virus isolation, thus sequences from each the swab and isolate had been wanted to acquire full subtype information. Haplotype networks revealed haplotype frequency shifts and the looks or lack of low-frequency haplotypes following isolation. The outcomes from this research revealed that isolation of untamed fowl avian influenza viruses in hen eggs results in skewed populations which might be totally different than the enter populations.
Consensus sequence modifications from virus isolation can result in flawed phylogenetic inferences, and subtype detection is biased. These outcomes recommend that for genomic research of untamed fowl influenza viruses the organic discipline ought to transfer away from hen egg isolation in the direction of immediately sequencing the virus from host samples.
Utilizing geospatial strategies to measure the danger of environmental persistence of avian influenza virus in South Carolina
Avian influenza (AIV) is a extremely contagious virus that may infect each wild birds and home poultry. This research aimed to outline areas inside the state of South Carolina (SC) at heightened threat for environmental persistence of AIV utilizing geospatial strategies. Environmental elements identified to affect AIV survival had been recognized by means of the printed literature and utilizing a multi-criteria choice evaluation with GIS was carried out.
Avian Influenza Hemagglutinin Peptide |
|
MBS153184-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Avian Influenza Hemagglutinin Peptide |
|
PM-4005P |
ProSci |
0.05 mg |
EUR 99 |
Avian Influenza Hemagglutinin Peptide |
|
PM-4006P |
ProSci |
0.05 mg |
EUR 99 |
Avian Influenza Hemagglutinin 2 Peptide |
|
3909P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (NT) Avian Influenza Hemagglutinin 2 peptide |
Avian Influenza Hemagglutinin 3 Peptide |
|
3911P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) Avian Influenza Hemagglutinin 3 peptide |
Avian Influenza Hemagglutinin 4 Peptide |
|
3913P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) Avian Influenza Hemagglutinin 4 peptide |
Avian Influenza Hemagglutinin 2 Peptide |
|
MBS152500-005mg |
MyBiosource |
0.05mg |
EUR 175 |
Avian Influenza Hemagglutinin 2 Peptide |
|
MBS152500-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Avian Influenza Hemagglutinin 3 Peptide |
|
MBS152685-005mg |
MyBiosource |
0.05mg |
EUR 175 |
Avian Influenza Hemagglutinin 3 Peptide |
|
MBS152685-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Avian Influenza Hemagglutinin 4 Peptide |
|
MBS153045-005mg |
MyBiosource |
0.05mg |
EUR 175 |
Avian Influenza Hemagglutinin 4 Peptide |
|
MBS153045-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Avian Influenza Hemagglutinin 3 Peptide |
|
PM-4007P |
ProSci |
0.05 mg |
EUR 99 |
Avian Influenza Hemagglutinin 3 Peptide |
|
PM-4008P |
ProSci |
0.05 mg |
EUR 99 |
Avian Influenza Hemagglutinin 3 Peptide |
|
PM-4009P |
ProSci |
0.05 mg |
EUR 99 |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
7821P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) Avian Influenza A H7N9 Hemagglutinin Peptide |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
7823P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) Avian Influenza A H7N9 Hemagglutinin Peptide |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
7825P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) Avian Influenza A H7N9 Hemagglutinin Peptide |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
MBS154004-005mg |
MyBiosource |
0.05mg |
EUR 175 |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
MBS154004-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
MBS154019-005mg |
MyBiosource |
0.05mg |
EUR 175 |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
MBS154019-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
MBS154155-005mg |
MyBiosource |
0.05mg |
EUR 175 |
Avian Influenza A H7N9 Hemagglutinin Peptide |
|
MBS154155-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
Influenza A H5N1 (Avian) Hemagglutinin, N-Terminal Peptide |
|
11-559 |
ProSci |
0.05 mg |
EUR 645 |
|
Description: Influenza A H5N1 (Avian) Hemagglutinin, N-Terminal Peptide |
Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide |
|
11-557 |
ProSci |
0.05 mg |
EUR 632.4 |
|
Description: Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide |
Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide |
|
11-558 |
ProSci |
0.05 mg |
EUR 645 |
|
Description: Influenza A H5N1 (Avian) Hemagglutinin (Middle Region) Peptide |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide |
|
MBS633819-005mg |
MyBiosource |
0.05mg |
EUR 880 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide |
|
MBS633819-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3820 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN), Control Peptide |
|
MBS658813-005mg |
MyBiosource |
0.05mg |
EUR 700 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN), Control Peptide |
|
MBS658813-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2990 |
Avian Influenza Hemagglutinin 1 Antibody |
|
24454 |
SAB |
100ul |
EUR 479 |
Avian Influenza Hemagglutinin 1 Antibody |
|
24454-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin 1 Antibody |
|
MBS151143-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza Hemagglutinin 1 Antibody |
|
MBS151143-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza Hemagglutinin 1 Antibody |
|
MBS9410662-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Avian Influenza Hemagglutinin 1 Antibody |
|
MBS9410662-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide (Bird Flu) |
|
MBS658994-005mg |
MyBiosource |
0.05mg |
EUR 395 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide (Bird Flu) |
|
MBS658994-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1630 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) Control Peptide (Bird Flu) |
|
MBS659545-005mg |
MyBiosource |
0.05mg |
EUR 395 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) Control Peptide (Bird Flu) |
|
MBS659545-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1630 |
Avian Influenza Hemagglutinin Antibody |
|
3425-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
|
3425-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
|
3427-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
|
3427-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
|
24276 |
SAB |
100ul |
EUR 479 |
Avian Influenza Hemagglutinin Antibody |
|
24276-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin Antibody |
|
24277 |
SAB |
100ul |
EUR 479 |
Avian Influenza Hemagglutinin Antibody |
|
24277-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin Antibody |
|
MBS151256-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza Hemagglutinin Antibody |
|
MBS151256-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza Hemagglutinin Antibody |
|
MBS150485-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza Hemagglutinin Antibody |
|
MBS150485-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza Hemagglutinin Antibody |
|
MBS9401705-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Avian Influenza Hemagglutinin Antibody |
|
MBS9401705-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Avian Influenza Hemagglutinin Antibody |
|
MBS9404745-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Avian Influenza Hemagglutinin Antibody |
|
MBS9404745-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Avian Influenza Hemagglutinin 2 Antibody |
|
24449 |
SAB |
100ul |
EUR 479 |
Avian Influenza Hemagglutinin 2 Antibody |
|
24449-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin 3 Antibody |
|
24450 |
SAB |
100ul |
EUR 479 |
Avian Influenza Hemagglutinin 3 Antibody |
|
24450-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin 4 Antibody |
|
24451 |
SAB |
100ul |
EUR 479 |
Avian Influenza Hemagglutinin 4 Antibody |
|
24451-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza A Hemagglutinin Antibody |
|
GWB-68DB90 |
GenWay Biotech |
0.1 mg |
Ask for price |
Avian Influenza Hemagglutinin 3 Antibody |
|
MBS151039-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza Hemagglutinin 3 Antibody |
|
MBS151039-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza Hemagglutinin 4 Antibody |
|
MBS151450-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza Hemagglutinin 4 Antibody |
|
MBS151450-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza Hemagglutinin 2 Antibody |
|
MBS150283-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza Hemagglutinin 2 Antibody |
|
MBS150283-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza Hemagglutinin 3 Antibody |
|
MBS9404749-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Avian Influenza Hemagglutinin 3 Antibody |
|
MBS9404749-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Avian Influenza Hemagglutinin 4 Antibody |
|
MBS9404916-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Avian Influenza Hemagglutinin 4 Antibody |
|
MBS9404916-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Avian Influenza Hemagglutinin 2 Antibody |
|
MBS9408563-01mL |
MyBiosource |
0.1mL |
EUR 495 |
Avian Influenza Hemagglutinin 2 Antibody |
|
MBS9408563-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Influenza Hemagglutinin (HA) Peptide |
|
A6004-25 |
ApexBio |
25 mg |
EUR 312 |
|
|
|
Description: Tag Peptides |
Influenza Hemagglutinin (HA) Peptide |
|
A6004-5 |
ApexBio |
5 mg |
EUR 79.2 |
|
|
|
Description: Tag Peptides |
Influenza Hemagglutinin (HA) Peptide |
|
A6004-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 160 |
|
|
|
Description: Tag Peptides |
Influenza Hemagglutinin (HA) Peptide |
|
MBS385481-10mg |
MyBiosource |
10mg |
EUR 230 |
Influenza Hemagglutinin (HA) Peptide |
|
MBS385481-25mg |
MyBiosource |
25mg |
EUR 465 |
Influenza Hemagglutinin (HA) Peptide |
|
MBS385481-5mg |
MyBiosource |
5mg |
EUR 165 |
Influenza Hemagglutinin (HA) Peptide |
|
MBS385481-5x25mg |
MyBiosource |
5x25mg |
EUR 2080 |
Influenza A, Avian, H6N1, Hemagglutinin (HA) |
|
MBS645330-01mg |
MyBiosource |
0.1mg |
EUR 650 |
Influenza A, Avian, H6N1, Hemagglutinin (HA) |
|
MBS645330-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2765 |
Influenza A, Avian, H6N1, Hemagglutinin (HA) |
|
MBS6006346-01mg |
MyBiosource |
0.1(mg |
EUR 680 |
Influenza A, Avian, H6N1, Hemagglutinin (HA) |
|
MBS6006346-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2920 |
Avian Influenza H5N1 Hemagglutinin (NT) Antibody |
|
3909-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Avian Influenza Hemagglutinin 2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza H5N1 Hemagglutinin (NT) Antibody |
|
3909-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Avian Influenza Hemagglutinin 2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
7821-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3). |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
7821-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3). |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
7823-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3). |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
7823-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3). |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
7825-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3). |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
7825-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3). |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
MBS153473-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
MBS153473-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
MBS153575-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
MBS153575-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
MBS153697-01mg |
MyBiosource |
0.1mg |
EUR 445 |
Avian Influenza A H7N9 Hemagglutinin Antibody |
|
MBS153697-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
Avian Influenza H5N1 Hemagglutinin (IN1) Antibody |
|
3911-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Avian Influenza Hemagglutinin 3 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza H5N1 Hemagglutinin (IN1) Antibody |
|
3911-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Avian Influenza Hemagglutinin 3 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza H5N1 Hemagglutinin (IN2) Antibody |
|
3913-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Avian Influenza Hemagglutinin 4 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza H5N1 Hemagglutinin (IN2) Antibody |
|
3913-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Avian Influenza Hemagglutinin 4 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza H5N1 Hemagglutinin (IN3) Antibody |
|
3925-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: Avian Influenza Hemagglutinin 1 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza H5N1 Hemagglutinin (IN3) Antibody |
|
3925-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: Avian Influenza Hemagglutinin 1 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Influenza A H5N1 Hemagglutinin Peptide |
|
abx060606-005mg |
Abbexa |
0.05 mg |
EUR 828 |
|
|
Influenza A H5N1 Hemagglutinin Peptide |
|
abx060606-100g |
Abbexa |
100 µg |
Ask for price |
Influenza A H5N1 Hemagglutinin Peptide |
|
abx060606-10g |
Abbexa |
10 µg |
EUR 537.5 |
Influenza A H5N1 Hemagglutinin Peptide |
|
abx060606-50g |
Abbexa |
50 µg |
Ask for price |
Influenza PR8 Hemagglutinin Peptide (110-119) |
|
H-6312.0005 |
Bachem |
5.0mg |
EUR 327.6 |
|
Description: Sum Formula: C63H90N14O16; CAS# [132031-50-6] net |
Influenza PR8 Hemagglutinin Peptide (110-119) |
|
H-6312.0025 |
Bachem |
25.0mg |
EUR 1197.6 |
|
Description: Sum Formula: C63H90N14O16; CAS# [132031-50-6] net |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00117 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00129 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00130 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00153 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00154 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00155 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00156 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza Antibody (A Hemagglutinin H5) (Avian H5N1) |
|
GWB-T00157 |
GenWay Biotech |
1 mg |
Ask for price |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS632056-01mg |
MyBiosource |
0.1mg |
EUR 1200 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS632056-5x01mg |
MyBiosource |
5x0.1mg |
EUR 5245 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS609588-01mg |
MyBiosource |
0.1mg |
EUR 680 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS609588-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS608939-1mg |
MyBiosource |
1mg |
EUR 1070 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS608939-5x1mg |
MyBiosource |
5x1mg |
EUR 4660 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS609096-02mg |
MyBiosource |
0.2mg |
EUR 725 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS609096-5x02mg |
MyBiosource |
5x0.2mg |
EUR 3100 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS609150-01mg |
MyBiosource |
0.1mg |
EUR 680 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) |
|
MBS609150-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
Polyclonal Avian Influenza A H7N9 Hemagglutinin Antibody |
|
APR10994G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Hemagglutinin . This antibody is tested and proven to work in the following applications: |
Polyclonal Avian Influenza A H7N9 Hemagglutinin Antibody |
|
APR10995G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Hemagglutinin . This antibody is tested and proven to work in the following applications: |
Polyclonal Avian Influenza A H7N9 Hemagglutinin Antibody |
|
APR10996G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza A H7N9 Hemagglutinin . This antibody is tested and proven to work in the following applications: |
Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag |
|
REC31991-100 |
The Native Antigen Company |
0.1 |
EUR 301.29 |
|
|
|
Description: Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein. |
Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag |
|
REC31991-500 |
The Native Antigen Company |
0.5 |
EUR 1057.09 |
|
|
|
Description: Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein. |
Hemagglutinin (48-68) / Influenza virus Peptide |
|
abx266859-1ml |
Abbexa |
1 ml |
EUR 475 |
Hemagglutinin (48-68) / Influenza virus Peptide |
|
abx266859-200l |
Abbexa |
200 µl |
EUR 225 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS632337-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS632337-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2700 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS632515-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS632515-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2700 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS630004-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS630004-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2700 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) (Bird Flu) |
|
MBS629237-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) (Bird Flu) |
|
MBS629237-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2700 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (PE) |
|
MBS6251929-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (PE) |
|
MBS6251929-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (AP) |
|
MBS6248038-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (AP) |
|
MBS6248038-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS609567-01mg |
MyBiosource |
0.1mg |
EUR 855 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS609567-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3685 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS633077-01mg |
MyBiosource |
0.1mg |
EUR 855 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS633077-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3685 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS631658-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) (Bird Flu) |
|
MBS631658-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2700 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (HRP) |
|
MBS6250975-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (HRP) |
|
MBS6250975-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (APC) |
|
MBS6268892-01mL |
MyBiosource |
0.1mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (APC) |
|
MBS6268892-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (FITC) |
|
MBS6249976-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (FITC) |
|
MBS6249976-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (Biotin) |
|
MBS6249053-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (Biotin) |
|
MBS6249053-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A H5N1 (Avian Flu) Hemagglutinin Antibody Pair Set |
|
ABPR-ZB322 |
Creative Diagnostics |
5 plates, 15 plates |
Ask for price |
|
Description: Quantitative determination of H5N1 Hemagglutinin |
Influenza A H5N1 (Avian Flu) Hemagglutinin/HA ELISA Pair Set |
|
MBS8119620-15Plates |
MyBiosource |
15Plates |
EUR 780 |
Influenza A H5N1 (Avian Flu) Hemagglutinin/HA ELISA Pair Set |
|
MBS8119620-5Plates |
MyBiosource |
5Plates |
EUR 425 |
Influenza A H5N1 (Avian Flu) Hemagglutinin/HA ELISA Pair Set |
|
MBS8119620-5x15Plates |
MyBiosource |
5x15Plates |
EUR 3360 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 405) |
|
MBS6252947-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 405) |
|
MBS6252947-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 490) |
|
MBS6253987-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 490) |
|
MBS6253987-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 550) |
|
MBS6255027-01mL |
MyBiosource |
0.1(mL |
EUR 1010 |
Influenza A, Avian, H5N1, Hemagglutinin (HA) (Bird Flu) (MaxLight 550) |
|
MBS6255027-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4405 |
Threat was outlined utilizing 5 classes following the World Group for Animal Well being Threat Evaluation Tips. Lower than 1% of 1km grid cells in SC confirmed a excessive threat of AIV persistence. Roughly 2% – 17% of counties with excessive or very excessive environmental threat additionally had medium to very excessive numbers of economic poultry operations. Outcomes can be utilized to enhance surveillance actions and to tell biosecurity practices and emergency preparedness efforts.